Which nerve block eases hip fracture pain best before surgery?

NCT ID NCT07716358

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This trial compares two ultrasound-guided nerve blocks—fascia iliaca block and femoral nerve block—for controlling pain in people with a broken hip (proximal femur fracture) before they receive spinal anesthesia. The goal is to see which block provides better pain relief, helping patients get into position for the spinal injection more comfortably. The study includes adults with hip fractures who are otherwise healthy (ASA I or II) and excludes those with certain risks like bleeding disorders or allergies to the anesthetic.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nerve block (fascia iliaca block or femoral nerve block) with local anesthetic (bupivacaine)
What this could lead to
If one block proves better, it could become the preferred method for easing pain before spinal anesthesia in hip fracture patients.
What could go wrong
This is a small, single-center trial, so results may not apply broadly. Both blocks carry rare risks like infection or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

84 people

The number who actually took part.

Started

Jan 2026

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ASA I\&II status patients coming for proximal femur fracture surgery Exclusion Criteria: * Patients with history of neurological disease (Alzheimer, dementia), * Patients with known contraindication to regional anaesthesia (e.g., signs of infection at site of block, coagulation abnormality i.e. INR \>1.55, platelet count \<80,000) * Patients with ASA III and IV status and patients with Known allergy to the study drug were excluded from study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nerve block assessment are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hip fracture Proximal Femoral Fractures

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sughra Shafi Medical Complex

    Chak Ninety-five North Branch, Punjab Province, 51600, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.